GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹84 Cr | ₹88 Cr | ₹74 Cr | ₹74 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GLAND PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2023 | ₹84 Cr |
Mar2022 | ₹88 Cr |
Mar2021 | ₹74 Cr |
Mar2020 | ₹74 Cr |
How is Deferred Tax Assets / Liabilities of GLAND PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹84 Cr | -4.05 | |
Mar2022 | ₹88 Cr | 18.79 | |
Mar2021 | ₹74 Cr | -0.23 | |
Mar2020 | ₹74 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹29,510.1 Cr | 0.9% | 1% | 32.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,470.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹112,990.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,846.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,849.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,742.1 Cr | -1% | -2.4% | 28.4% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | 0.9% |
1% |
32.4% |
SENSEX | 1.7% |
0.7% |
19.2% |
You may also like the below Video Courses